These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 26742726)
1. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Ni W; Han Y; Zhao J; Wei C; Cui J; Wang R; Liu Y Int J Antimicrob Agents; 2016 Feb; 47(2):107-16. PubMed ID: 26742726 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis. Mei H; Yang T; Wang J; Wang R; Cai Y J Antimicrob Chemother; 2019 Dec; 74(12):3423-3431. PubMed ID: 31377765 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis. Kengkla K; Kongpakwattana K; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N J Antimicrob Chemother; 2018 Jan; 73(1):22-32. PubMed ID: 29069421 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline. Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468 [TBL] [Abstract][Full Text] [Related]
5. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963 [TBL] [Abstract][Full Text] [Related]
8. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia? Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacies of three empirically-selected antibiotics for treating Acinetobacter baumannii pulmonary infection: experience from a teaching hospital in China . Li P; Wang X; Wang W; Zhao X Int J Clin Pharmacol Ther; 2017 Jul; 55(7):588-593. PubMed ID: 28291507 [TBL] [Abstract][Full Text] [Related]
10. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. Navon-Venezia S; Leavitt A; Carmeli Y J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223 [TBL] [Abstract][Full Text] [Related]
11. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis. Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335 [TBL] [Abstract][Full Text] [Related]
12. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009. Morfin-Otero R; Dowzicky MJ Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii. Kwon SH; Ahn HL; Han OY; La HO Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855 [TBL] [Abstract][Full Text] [Related]
15. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Schafer JJ; Goff DA; Stevenson KB; Mangino JE Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model. Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729 [TBL] [Abstract][Full Text] [Related]
17. Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections. Goff DA; Bauer KA; Mangino JE Clin Infect Dis; 2014 Dec; 59 Suppl 6():S381-7. PubMed ID: 25371514 [TBL] [Abstract][Full Text] [Related]
18. Tigecycline-Containing Regimens and Multi Drug-Resistant Sodeifian F; Zangiabadian M; Arabpour E; Kian N; Yazarlou F; Goudarzi M; Centis R; Seghatoleslami ZS; Kameh MC; Danaei B; Goudarzi H; Nasiri MJ; Sotgiu G; Migliori GB Microb Drug Resist; 2023 Aug; 29(8):344-359. PubMed ID: 37192494 [No Abstract] [Full Text] [Related]
19. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018 [TBL] [Abstract][Full Text] [Related]
20. A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii. Ni WT; Liang BB; Cai Y; Liu YP; Bai N; Cui JC; Wang R Pak J Pharm Sci; 2014 May; 27(3):463-7. PubMed ID: 24811802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]